*sponsored by StockstoTrade
Good day, 360!
Here are our top movers today. And if you’ve been delaying getting into Bullseye Trades (Jeff Bishop’s #1 Pick of the Week) – here’s your chance. Only 7 bucks to dip your toe in🦶.
Yes… seven bucks.
FOCUS LIST🔎
LUNR – Up over 20% in the pre-market after being awarded a $116.9 million NASA Lunar Contract Award
EBS – Up over 20% in pre after its Mpox and Smallpox vaccine receives U.S FDA approval for Mpox Indication as Mpox outbreak continues across Africa
BNRG – Up over 120% in pre after reporting first half financials, $500 million potential project pipeline
*sponsored by StockstoTrade
After 4 years of secrecy, one historic discovery is provoking veteran trader, Tim Bohen and his team of 11 developers, to go “beyond AI” and officially unveil the unique stock-scoring-system responsible for pinpointing dozens of 100%+ gains in both bear AND bull markets…
Attend This World AI Premiere!
HOTLIST🔥
LUNR – Up over 20% in the pre-market after being awarded a $116.9 million NASA Lunar Contract Award
Intuitive Machines, Inc. (LUNR) designs, manufactures, and operates space products and services in the United States.
In the after-hours yesterday, the company announced that NASA had awarded it a $116.9 million contract to deliver six science and technology payloads, including one European Space Agency-led drill suite to the Moon’s South Pole.
This award will leverage Intuitive Machines’ lunar delivery, data transmission, and autonomous operation capabilities to explore the region targeted for sustained human operations.
The stock traded up over 20% in the pre-market in reaction to the news.
The first target for bulls is the after hours high at $6.10.
Beyond that, $6.50, $7.30, $8.50 and $9.50 come into play.
Below $6.10, targets to the downside are $5, $4.70 and $4.50.
EBS – Up over 20% in pre after its Mpox and Smallpox vaccine receives U.S FDA approval for Mpox Indication as Mpox outbreak continues across Africa
Emergent BioSolutions Inc. (EBS) is a life sciences company that provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.
In the after-hours yesterday, the company announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the expansion of the indication for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) to include prevention of mpox disease in individuals determined to be at high risk for mpox infection.
The approval is based on previously available human safety data and data from a well-controlled animal study in which ACAM2000® vaccine was shown to be effective in protecting against mpox virus exposure.
ACAM2000® is a single-dose vaccine administered percutaneously via a bifurcated needle that is dipped into the vaccine solution and the skin is pricked several times in the upper arm with a droplet of the vaccine.
The vaccine was first approved by the FDA in 2007 for active immunization for the prevention of smallpox disease in individuals determined to be at high risk for smallpox infection.
The stock traded up over 20% in the pre-market in reaction to the news.
The $10.10 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $10.40, $10.60 and then the pre-market high at $10.80. Beyond that, $11.96, $12.74, and $13.28 come into play.
Below $10.10, targets to the downside are $10, $9.66, $8.91, $8.01 and then $7.50.
And… HURRY!!!
Only 100 29 seats left in Jason’s BACK TO SCHOOL SALE.
Be sure to apply coupon code: SAVE60
The coupon lowers $1,497 yearly to $598 grandfathered
Or $2,497 for a 5 year membership to $998 [BEST DEAL]
BNRG – Up over 120% in pre after reporting first half financials, $500 million potential project pipeline
Brenmiller Energy Ltd. (BNRG) develops, produces, markets, and sells thermal energy storage (TES) systems based on its proprietary and patented technology that enables electrification and decarbonization.
In the after-hours yesterday, the company reported first half 2024 financial results.
Highlights Include:
Brenmiller entered a definitive agreement for a $1.05 million private placement priced at a 52% premium to market on August 2, 2024, with an existing institutional shareholder which will have the right to make a further investment an additional 1 million shares, in the event the Company’s ordinary shares close at or above $2.50 per share within the next 12 months
Projects currently in development and construction phases are expected to produce multiple recurring revenue streams
Expanding bGen™ into new application for cooling AI data centers with the development of a Cold Thermal Energy Storage solution, the bGen™ Cool
Management Commentary
“Our pioneering bGen™ thermal battery continues to support the growing and mostly unmet need for on-demand access to sustainable heat. We have built an impressive project pipeline, potentially worth up to $500 million in value
Summary of Financial Results
Income Statement: Operating loss narrowed for the six months ended June 30, 2024, to $5.38 million, compared to $5.42 million for the same period in 2023.
Balance Sheet: As of June 30, 2024, Brenmiller had cash and cash equivalents and restricted deposits of $6.99 million, a net increase of $3.78 million from $3.21 million on December 31, 2023.
The stock traded up over 120% in the pre-market in reaction to the news.
The first target for bulls is after-hours resistance at $1.60 and then the pre-market high at $1.74. Beyond that, $1.90, $2.10 and $2.50 come into play.
Below $1.60, targets to the downside are $1.40, $1.20, $1, $0.85, $0.75 and then a gap fill at $0.6451.
MARKET NEWS 📰
P.S. Make sure you text “RAGE” to (888) 404-5747 to get all of our latest HOT STOCK ideas!
Questions or concerns about our products? Email Support@360wallstreet.io © Copyright 2022, RagingBull
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer
*Sponsored content: We’re a proud affiliate for StockstoTrade, meaning if you click a link for a product or service, we may earn a commission at no extra cost to you. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals.
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
